An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
GoodRx Holdings Inc. (GDRX) is set to release its Q1 2022 financial results after U.S. markets close on May 9, 2022. Management will hold a conference call at 2:00 p.m. PT to discuss the results and the company’s outlook. Interested parties can access the information via their investor relations website. GoodRx has saved consumers over $35 billion since its inception, solidifying its position as a leading digital healthcare platform.
Positive
Scheduled conference call for Q1 2022 results indicates transparency and engagement with investors.
GoodRx has helped consumers save over $35 billion since 2011, indicating strong market position.
Negative
None.
SANTA MONICA, Calif.--(BUSINESS WIRE)--
GoodRx Holdings Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced it will release its first quarter 2022 financial results after U.S. markets close on Monday, May 9, 2022. GoodRx management will hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the results and the Company’s business outlook. Prior to the call, GoodRx will issue a press release containing a link to a shareholder letter and the Company’s first quarter 2022 financial results on its investor relations website at https://investors.goodrx.com.
Approximately one hour after completion of the live call, an archived version of the webcast will be available on the Company’s investor relations website at https://investors.goodrx.com for at least 30 days.
About GoodRx
GoodRx is a leading consumer-focused digital healthcare platform. Our technology delivers strong savings, trusted information and access to care to make healthcare affordable and convenient for all Americans. Since 2011, we have helped consumers save over $35 billion and are one of the most downloaded medical apps over the past decade.
